BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30412241)

  • 1. Genome-wide association study of cervical cancer suggests a role for ARRDC3 gene in human papillomavirus infection.
    Takeuchi F; Kukimoto I; Li Z; Li S; Li N; Hu Z; Takahashi A; Inoue S; Yokoi S; Chen J; Hang D; Kuroda M; Matsuda F; Mizuno M; Mori S; Wu P; Tanaka N; Matsuo K; Kamatani Y; Kubo M; Ma D; Shi Y
    Hum Mol Genet; 2019 Jan; 28(2):341-348. PubMed ID: 30412241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.
    Adebamowo SN; Adeyemo AA; Rotimi CN; Olaniyan O; Offiong R; Adebamowo CA;
    BMC Med Genet; 2020 Nov; 21(1):231. PubMed ID: 33225922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study of HPV-associated cervical cancer in Japanese women.
    Miura K; Mishima H; Kinoshita A; Hayashida C; Abe S; Tokunaga K; Masuzaki H; Yoshiura K
    J Med Virol; 2014 Jul; 86(7):1153-8. PubMed ID: 24700089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer.
    Lai ZZ; Ni-Zhang ; Pan XL; Song L
    J Int Med Res; 2013 Aug; 41(4):1027-36. PubMed ID: 23816930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.
    Chagas BS; Lima RCP; Paiva Júnior SSL; Silva RCO; Cordeiro MN; Silva Neto JDC; Batista MVA; Silva AJD; Gurgel APAD; Freitas AC
    Cytokine; 2019 Jan; 113():99-104. PubMed ID: 29935877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China.
    Hu JM; Sun Q; Li L; Liu CX; Chen YZ; Zou H; Pang LJ; Zhao J; Yang L; Cao YW; Cui XB; Qi Y; Liang WH; Zhang WJ; Li F
    Int J Clin Exp Pathol; 2014; 7(9):6165-71. PubMed ID: 25337265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
    Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese.
    Chan PK; Cheung TH; Lin CK; Siu SS; Yim SF; Lo KW; Cheung JL; Tam AO; Tang JW
    J Med Virol; 2007 Jul; 79(7):970-6. PubMed ID: 17516530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between susceptibility loci in cGAS-STING pathway, MHC gene and HPV infection on the risk of cervical precancerous lesions in Chinese population.
    Xiao D; Huang W; Ou M; Guo C; Ye X; Liu Y; Wang M; Zhang B; Zhang N; Huang S; Zang J; Zhou Z; Wen Z; Zeng C; Wu C; Huang C; Wei X; Yang G; Jing C
    Oncotarget; 2016 Dec; 7(51):84228-84238. PubMed ID: 27705945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer.
    Deshpande A; Nolan JP; White PS; Valdez YE; Hunt WC; Peyton CL; Wheeler CM
    J Infect Dis; 2005 Mar; 191(6):969-76. PubMed ID: 15717274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analysis of the entire HLA, partial non-HLA and HPV for Chinese women with cervical cancer.
    Wu Y; Zhang Q; Liu B; Yu G
    J Med Virol; 2008 Oct; 80(10):1808-13. PubMed ID: 18712835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.
    Gillio-Tos A; Bicalho Mda G; Fiano V; Grasso C; Tarallo V; De Marco L; Trevisan M; Xavier M; Slowik R; Carvalho NS; Maestri CA; Lacerda HM; Zugna D; Richiardi L; Merletti F
    BMC Cancer; 2012 Dec; 12():618. PubMed ID: 23265140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathway analysis of cervical cancer genome-wide association study highlights the MHC region and pathways involved in response to infection.
    Chen D; Enroth S; Ivansson E; Gyllensten U
    Hum Mol Genet; 2014 Nov; 23(22):6047-60. PubMed ID: 24934695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levels.
    Ramachandran D; Schürmann P; Mao Q; Wang Y; Bretschneider LM; Speith LM; Hülse F; Enßen J; Bousset K; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Tarbiat J; Runnebaum I; Dürst M; Hein A; Koch M; Ruebner M; Ekici A; Beckmann MW; Fasching PA; Luyten A; Petry KU; Hillemanns P; Dörk T
    Int J Cancer; 2020 Nov; 147(9):2458-2468. PubMed ID: 32580243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer.
    Deshpande A; Wheeler CM; Hunt WC; Peyton CL; White PS; Valdez YE; Nolan JP
    J Infect Dis; 2008 Feb; 197(3):371-81. PubMed ID: 18248301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of toll-like receptor gene polymorphisms and its interaction with HPV infection in determining the susceptibility of cervical cancer in Chinese Han population.
    Jin Y; Qiu S; Shao N; Zheng J
    Mamm Genome; 2017 Jun; 28(5-6):213-219. PubMed ID: 28497211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes polymorphisms are correlated with susceptibility to HPV infection in patients with and without cervical intraepithelial lesion.
    Tavares MC; de Lima Júnior SF; Coelho AV; Marques TR; de Araújo DH; Heráclio Sde A; Amorim MM; de Souza PR; Crovella S
    Ann Hum Biol; 2016 May; 43(3):261-8. PubMed ID: 26079218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
    Zehbe I; Mytilineos J; Wikström I; Henriksen R; Edler L; Tommasino M
    Hum Immunol; 2003 May; 64(5):538-42. PubMed ID: 12691704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
    Alsbeih GA; Al-Harbi NM; Bin Judia SS; Khoja HA; Shoukri MM; Tulbah AM
    Cancer; 2017 Jul; 123(13):2459-2466. PubMed ID: 28393355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA DOA1 and DOB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection.
    Ferrera A; Olivo A; Alaez C; Melchers WJ; Gorodezky C
    Hum Biol; 1999 Jun; 71(3):367-79. PubMed ID: 10380373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.